OOIR: Observatory of International Research

Papers

(The TQCC of Journal of the Peripheral Nervous System is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Loss of function MPZ mutation causes milder CMT1B neuropathy	302
Issue Information	51
Issue Information	48
	31
Featured Cover	30
	23
	20
Lack of effect from genetic deletion of Hdac6 in a humanized mouse model of CMT2D	19
A severe case of neuroleukemiosis caused by B cell chronic lymphocytic leukemia, presenting as mononeuritis multiplex	18
	16
Abstracts	15
Toxic medications in Charcot–Marie–Tooth patients: A systematic review	15
ABSTRACT	15
A recurrent MORC2 mutation causes Charcot‐Marie‐Tooth disease type 2Z	14
The autoimmune vulnerability of the node of Ranvier	14
Sural nerve biopsy utility by masked assessment of individual histologic preparations	12
Long‐term and low‐dose rituximab treatment for chronic inflammatory demyelinating polyneuropathy	12
	12
Identical late motor responses in early Guillain‐Barré syndrome: A‐waves and repeater F‐waves	11
PNS Abstracts 2023	11
Evidence for spontaneous regulation of the humoral IgM anti‐GM1 autoimmune response by IgG antibodies in multifocal motor neuropathy patients	10
	10
Issue Information	10
Phase 2a randomized controlled study investigating the safety and efficacy of PDA‐002 in diabetic peripheral neuropathy	9
Electrodiagnostic methods to verify Guillain‐Barré syndrome subtypes in Istanbul: A prospective multicenter study	9

	9
Prognostic value of neurofilament light in blood in patients with polyneuropathy: A systematic review	9
Frequency dependent, reversible focused ultrasound suppression of evoked potentials in the reflex arc in an anesthetized animal	8
Antecedent infections in Guillain‐Barré syndrome in endemic areas of arbovirus transmission: A multinational case‐control study	8
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy‐induced peripheral neurotoxicity: The role of nerve excitability testing	8
Recruiting for an International Rare Disease Clinical Trial Readiness Study during the COVID‐19 pandemic: Challenges and solutions	8
Variations within Toll‐like receptor (TLR) and TLR signaling pathway‐related genes and their synergistic effects on the risk of Guillain‐Barré syndrome	8
Analysis of relapse by inflammatory Rasch‐built overall disability scale status in the PATH study of subcutaneous immunoglobulin in chronic inflammatory demyelinating polyneuropathy	8
Oxygen matters: Unraveling the role of oxygen in the neuronal response to cisplatin	7
Neuralgic amyotrophy presentation of acute intermittent porphyria: A case report	7
Retrospective analysis of response to rituximab in chronic inflammatory demyelinating polyneuropathy refractory to first‐line therapy	7
Reply to “Nerve ultrasound as a screening tool for inherited sensory neuronopathy”	7
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?	7
Broadening Research Priorities in Peripheral Neuropathy: A Response to “A Call to Action for Peripheral Neuropathy Research Funding—Time to Consolidate Funding Under One NIH Initiative?”	6
Distinguishing Chronic Inflammatory Demyelinating Polyneuropathy From Mimic Disorders: The Role of Statistical Modeling	6
Reply to the Letter to the Editor “Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?” by Kokubun N. et al.	6
Safety and Cost Analysis of Immunoglobulin Cessation Trials in Chronic Inflammatory Demyelinating Polyradiculoneuropathy	6
Hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: The ADVANCE‐CIDP 1 randomized controlled tria	6
Validation of the Korean version of inflammatory Rasch‐built Overall Disability Scale in patients with inflammatory neuropathy	6
Eculizumab as a Disease‐Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report	5
Abstracts of the 33rd annual meeting of the Japanese peripheral nerve society (JPNS)	5
Issue Information	5
Chronic inflammatory demyelinating polyneuropathy with hypertrophic nerves	5
	5
Featured Cover	5
Validation of an Artificial Intelligence driven framework to automatically detect red flag symptoms in screening for rare diseases in electronic health records: hereditary transthyretin amyloidosis po	5
Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy: Reply to Letter to the Editor	5
Electrodiagnostic subtyping in Guillain‐Barré syndrome: Use of criteria in practice based on a survey study in IGOS	5
	4
Validation of the parent‐proxy pediatric Charcot‐Marie‐Tooth disease quality of life outcome measure	4
Unusual upper limb features in SORD neuropathy	4
Corneal confocal microscopy in small and mixed fiber neuropathy—Comparison with skin biopsy and cold detection in a large prospective cohort	4
Plasma proteomic analysis on neuropathic pain in idiopathic peripheral neuropathy patients	4
A study concept of expeditious clinical enrollment for genetic modifier studies in Charcot–Marie–Tooth neuropathy 1A	4
	3
Issue Information	3
Nerve ultrasound as a screening tool for inherited sensory neuronopathy	3
Incidence and risk factors for developing chemotherapy‐induced neuropathic pain in 500 cancer patients: A file‐based observational study	3
A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course	3
The neuropathy in hereditary transthyretin amyloidosis: A narrative review	3
Issue Information	3
Dorsal root ganglia CSF1⁺ neuronal subtypes have different impact on macrophages and microglia after spared nerve injury	3
	3
Abstract	3
VitaminB6levels do not correlate with severity of neuropathy in chronic idiopathic axonal polyneuropathy	3
Wearables, sensors, and smart devices for the detection and monitoring of chemotherapy‐induced peripheral neurotoxicity: Systematic review and directions for future research	3
Clinical and genetic features of CMT2T in Italian patients confirm the importance of MME pathogenic variants in idiopathic, late‐onset axonal neuropathies	2
Conduction slowing, conduction block and temporal dispersion in demyelinating, dysmyelinating and axonal neuropathies: Electrophysiology meets pathology	2
Differential Impact of Metabolic Factors and Comorbidities on Peripheral Neuropathy	2
	2

Minimal invasive biopsies are highly sensitive for amyloid detection in hereditary transthyretin amyloidosis with polyneuropathy	2
Hip Dysplasia in Charcot–Marie–Tooth Disease: Insights From a Large Cohort of Children and Adolescents	2
Digital nerve reconstruction with a new composite silk fibroin nerve conduit	2
Autoimmune nodo‐paranodopathies 10 years later: Clinical features, pathophysiology and treatment	2
Serum anti‐GM2 and anti‐GalNAc‐GD1a ganglioside IgG antibodies are biomarkers for immune‐mediated polyneuropathies in cats	2
Associations of Guillain‐Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database	2
European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision	2
A call to action for peripheral neuropathy research funding—Time to consolidate funding under one NIH initiative?	2
Vitamin D levels do not correlate with severity of idiopathic peripheral neuropathy	2
Loss of MEGF10 Decreases the Number of Perisynaptic Schwann Cells and Innervation of Neuromuscular Junctions in Aging Mice	2
Current profile of Charcot‐Marie‐Tooth disease in Africa: A systematic review	2
Development of a functional outcome measure for riboflavin transporter deficiency	2
Initial findings using high‐resolution magnetic resonance imaging for visualisation of the sural nerve and surrounding anatomy in healthy volunteers at 7 Tesla	2
Leptospirosis‐induced acute acquired inflammatory neuropathy	2
Prediction of respiratory failure and prolonged mechanical ventilation in Guillain‐Barré syndrome: A prospective cohort study in Bangladesh	2
Cytokine Signature Unveils Subgroups of Patients With Immune‐Mediated Sensory Neuronopathies	2
The small fiber neuropathy—symptom inventory questionnaire (SFN‐SIQ) does not discriminate between patients with or without small fiber neuropathy	2
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome	2
Issue Information	2
Ofatumumab for treating autoimmune nodopathy	2
Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders	2
No evidence of improvement in neuropathy after renal transplantation in patients with end stage kidney disease	2